|
Q4 2023
|
5 |
75,152 |
ANNX, AKBA, AMWL, AADI
|
13F-HR
|
2/9/2024 |
000089534524000038 |
|
Q3 2023
|
6 |
58,509 |
AKBA, ANNX, AMWL, AADI
|
13F-HR
|
11/13/2023 |
000089534523000616 |
|
Q2 2023
|
6 |
76,866 |
ANNX, AMWL, AKBA, AADI
|
13F-HR
|
8/14/2023 |
000089534523000465 |
|
Q1 2023
|
6 |
75,678 |
ANNX, AMWL, AADI, AKBA
|
13F-HR
|
5/15/2023 |
000089534523000288 |
|
Q4 2022
|
6 |
86,935 |
AMWL, ANNX, AADI, AKBA
|
13F-HR
|
2/13/2023 |
000089534523000105 |
|
Q3 2022
|
7 |
103,853 |
ANNX, AMWL, GLOBAL BLOOD THERAPEUTICS IN, AADI
|
13F-HR
|
11/14/2022 |
000156761922019849 |
|
Q2 2022
|
7 |
53,878 |
AMWL, ANNX, ASMB, AADI
|
13F-HR
|
8/3/2022 |
000184400222000006 |
|
Q1 2022
|
7 |
59,037 |
AMWL, AILERON THERAPEUTICS INC, AADI, ANNX
|
13F-HR
|
5/13/2022 |
000184400222000005 |
|
Q4 2021
|
7 |
98,321 |
AMWL, ANNX, AKBA, AILERON THERAPEUTICS INC
|
13F-HR
|
2/9/2022 |
000184400222000001 |
|
Q3 2021
|
7 |
146,099 |
AMWL, ANNX, AILERON THERAPEUTICS INC, AKBA
|
13F-HR
|
11/15/2021 |
000184400221000005 |
|
Q2 2021
|
7 |
184,232 |
AMWL, ANNX, AILERON THERAPEUTICS INC, AKBA
|
13F-HR
|
8/11/2021 |
000184400221000004 |
|
Q1 2021
|
7 |
226,017 |
AMWL, ANNX, AILERON THERAPEUTICS INC, AKBA
|
13F-HR
|
5/12/2021 |
000184400221000003 |
|
Q4 2020
|
7 |
253,927 |
AMWL, ANNX, ASMB, AKBA
|
13F-HR
|
2/11/2021 |
000184400221000001 |